NEET · Biology

Human Health & Microbes in Human Welfare

Updated 18 Nov 2026 · 12,928 words · 2 sections · illustrated
NEET Biology covering Human Health & Disease (immunity, infectious diseases, cancer, AIDS, drugs) and Microbes in Human Welfare (household, industrial, sewage, biogas, biocontrol, biofertilisers).
Pathogenic MicrobesInfectious DiseasesImmune ResponseBeneficial MicrobesHuman Welfare UsescausestriggersenablesGS1 Society: Human Health & MicrobesMechanism: Competitive exclusion & immunityvlymbooq
Human Health Microbes in Human Welfare Concept Diagram — Shows how pathogenic microbes cause disease, trigger immune response, and how beneficial microbes enable human welfare applications. · Open the full diagram →

Human Health & Disease

Health is a state of complete physical, mental, and social well-being (WHO definition), not merely the absence of disease. It can be influenced by genetic disorders, infections, lifestyle (diet, exercise, stress), and environmental factors.

Common Human Diseases

Bacterial diseases: Typhoid (Salmonella typhi — Widal test), Pneumonia (Streptococcus pneumoniae and Haemophilus influenzae — alveoli fill with fluid), Plague (Yersinia pestis), Diphtheria (Corynebacterium diphtheriae), Tetanus (Clostridium tetani), Cholera (Vibrio cholerae — rice-water stools), TB (Mycobacterium tuberculosis).

Viral diseases: Common cold (Rhinovirus), Influenza (Orthomyxovirus), AIDS (HIV), Dengue (Flavivirus — Aedes mosquito), Chikungunya (Togavirus — Aedes), COVID-19 (SARS-CoV-2), Hepatitis B (Hepadnavirus), Rabies (Rhabdovirus — infected animal bite), Polio (Enterovirus — now eradicated in most countries).

Protozoan diseases: Malaria (Plasmodium vivax/falciparum/malariae/ovale — transmitted by female Anopheles mosquito), Amoebic dysentery (Entamoeba histolytica), Kala-azar/Leishmaniasis (Leishmania donovani — sandfly), Sleeping sickness (Trypanosoma gambiense — tsetse fly).

Fungal diseases: Ringworm (Trichophyton, Microsporum, Epidermophyton), Candidiasis (Candida albicans).

Helminthic diseases: Ascariasis (Ascaris lumbricoides — roundworm), Filariasis/Elephantiasis (Wuchereria bancrofti — mosquito), Tapeworm infection (Taenia solium — pork).

Example 1 — Diseases
Which mosquito transmits malaria?

a) Aedes   b) Culex   c) Female Anopheles   d) Male Anopheles
Solution: Option (c). Female Anopheles mosquito transmits the malarial parasite Plasmodium. Only female mosquitoes bite (males feed on nectar).

Immunity

The body's ability to recognise and defend against pathogens. Two types: Innate (non-specific) — present from birth, not pathogen-specific. Components: Physical barriers (skin, mucous membranes), Physiological barriers (stomach acid HCl, lysozyme in tears, saliva), Cellular barriers (phagocytes — neutrophils, macrophages, NK cells), Cytokine barriers (interferons — protect against viral infections). Acquired (specific) — develops after exposure to a pathogen. Attributes: Specificity, Diversity, Memory (faster and stronger response on second exposure — immunological memory).

Types of Acquired Immunity

Humoral immunity: B-lymphocytes produce antibodies (immunoglobulins) that circulate in blood and lymph. Antibody structure: 4 polypeptide chains (2 heavy + 2 light) forming a Y-shape. There are 5 classes: IgG (most abundant, crosses placenta — provides passive immunity to foetus), IgA (present in secretions — colostrum, saliva, tears), IgM (first antibody produced in primary response), IgE (involved in allergic reactions), IgD (B-cell receptor). Cell-mediated immunity: T-lymphocytes directly attack infected cells. Types: Helper T cells (TH) (activate B cells and other T cells), Cytotoxic T cells (TC) (kill infected cells), Suppressor T cells (Ts) (regulate immune response).

Vaccination & Immunisation

A vaccine contains weakened/dead pathogens or antigens that stimulate the immune system to produce memory cells. On subsequent exposure, the response is rapid and strong. Edward Jenner (1796) developed the first vaccine for smallpox using cowpox virus. Smallpox has been eradicated globally (WHO, 1979). The Expanded Programme on Immunisation (EPI) includes vaccines for TB (BCG), Polio (OPV/IPV), Diphtheria-Pertussis-Tetanus (DPT), Measles, MMR, Hepatitis B, and more.

Active vs Passive Immunity

Table: Active vs Passive Immunity
FeatureActive ImmunityPassive Immunity
Antibody sourceProduced by the body itselfReceived from outside
Immune responseYes — B and T cells are activatedNo — ready-made antibodies are given
MemoryImmunological memory is formedNo memory — temporary protection
DurationLong-lasting (years to lifetime)Short-term (weeks to months)
OnsetSlow (takes days to weeks)Immediate
Natural examplesInfection → recoveryMaternal antibodies (IgG via placenta, IgA via colostrum)
Artificial examplesVaccinationAntibody injection (anti-venom, anti-tetanus serum)
Example 1B — Immunity Types
Which type of immunity is provided by colostrum to a newborn?

a) Active natural   b) Passive natural   c) Active artificial   d) Passive artificial
Solution: Option (b). Colostrum (the first milk) contains IgA antibodies that provide passive natural immunity to the newborn. The baby receives ready-made antibodies from the mother. Vaccination is active artificial immunity; anti-venom is passive artificial immunity.

Lymphatic System & Immune Organs

The lymphatic system plays a crucial role in immunity. Lymph is the fluid that leaks from blood capillaries into intercellular spaces. It contains WBCs (especially lymphocytes) and is circulated through lymphatic vessels. Primary lymphoid organs: Bone marrow (B-lymphocytes mature here) and Thymus gland (T-lymphocytes mature here — located behind the sternum, largest in infants, atrophies with age). Secondary lymphoid organs: Lymph nodes (filter lymph, contain B and T cells), Spleen (filters blood, contains lymphocytes and macrophages — the graveyard of RBCs), Tonsils (protect respiratory tract), Peyer's patches (in the small intestine — protect gut), Appendix (vestigial but contains lymphoid tissue). Mucosa-Associated Lymphoid Tissue (MALT) — located in respiratory, digestive, and urogenital tracts forming the first line of defence at mucosal surfaces.

NEET Key — Lymphoid Organs
Bone marrow and thymus are PRIMARY lymphoid organs — lymphocytes are produced and mature here. All others (lymph nodes, spleen, tonsils, Peyer's patches, MALT) are SECONDARY lymphoid organs — lymphocytes interact with antigens here. Memory: B for Bone marrow, T for Thymus.
Example 1C — Immune Organs
T-lymphocytes mature in which organ?

a) Bone marrow   b) Thymus   c) Spleen   d) Lymph node
Solution: Option (b). T-lymphocytes (T cells) mature in the thymus gland. B-lymphocytes (B cells) mature in the bone marrow. Both are produced in the bone marrow but differentiate in different primary lymphoid organs.

Allergies & Autoimmune Diseases

Allergy: Exaggerated (hypersensitive) immune response to harmless environmental substances called allergens (pollen, dust mites, pet dander, certain foods, drugs). Mechanism: First exposure → allergens sensitise mast cells (IgE binds to FcεRI receptors). Subsequent exposure → allergen cross-links IgE on mast cells → mast cells degranulate → release histamine, leukotrienes, prostaglandins → vasodilation, bronchoconstriction, increased mucus, itching. Symptoms: sneezing, runny nose, watery eyes, rashes (urticaria), asthma, anaphylaxis (severe, life-threatening). Diagnosis: Skin prick test, serum IgE levels. Treatment: Antihistamines (block histamine H1 receptors — cetirizine, loratadine), corticosteroids, epinephrine (adrenaline — for anaphylaxis), immunotherapy (allergy shots — desensitisation).

Autoimmune diseases: The immune system mistakenly attacks self-antigens (failure of self-tolerance). Causes include genetic predisposition (HLA associations) and environmental triggers (infection, stress). Examples: Rheumatoid arthritis (autoantibodies against joint synovia — RF factor), Type 1 diabetes (T cells destroy pancreatic β-cells), Multiple sclerosis (T cells attack myelin sheath of neurons), Systemic Lupus Erythematosus (SLE — autoantibodies against DNA, nuclear antigens — butterfly rash on face), Graves' disease (autoantibodies stimulate TSH receptor on thyroid → hyperthyroidism), Hashimoto's thyroiditis (autoantibodies against thyroid → hypothyroidism), Myasthenia gravis (autoantibodies block acetylcholine receptors at neuromuscular junction → muscle weakness).

Immune System Disorders — Primary Immunodeficiencies

Severe Combined Immunodeficiency (SCID): A group of rare genetic disorders with absence of both B and T cell function (combined humoral and cell-mediated deficiency). Most severe form is X-linked SCID (mutation in IL2RG gene encoding the common gamma chain of cytokine receptors). "Bubble boy" disease — patients must live in sterile environments. Treatment: bone marrow transplantation, gene therapy (first successful human gene therapy was for ADA-SCID in 1990). Without treatment, death occurs within the first year from severe infections.

DiGeorge Syndrome (22q11.2 deletion syndrome): Microdeletion on chromosome 22. Results in thymic aplasia/hypoplasia (absent/underdeveloped thymus) → T-cell deficiency. Associated with cardiac abnormalities, characteristic facial features, cleft palate. Treatment: thymus transplantation, supportive care.

Chediak-Higashi Syndrome: Autosomal recessive disorder (LYST gene mutation). Defective phagocytosis due to abnormal lysosomal trafficking — neutrophils have giant granules that cannot fuse with phagosomes. Recurrent pyogenic infections, albinism (partial), peripheral neuropathy. Treatment: bone marrow transplant.

Chronic Granulomatous Disease (CGD): X-linked (most common) or autosomal recessive. Defect in NADPH oxidase enzyme complex in phagocytes → inability to produce ROS to kill engulfed bacteria. Recurrent infections with catalase-positive organisms (Staphylococcus aureus, Serratia, Aspergillus). Granuloma formation in various organs. Diagnosis: Nitroblue Tetrazolium (NBT) test — fails to turn blue (negative). Treatment: IFN-γ therapy, prophylactic antibiotics, BMT, gene therapy.

Hyper-IgE Syndrome (Job Syndrome): Autosomal dominant (STAT3 mutation). Extremely high serum IgE (>2000 IU/mL), recurrent staphylococcal skin abscesses ("cold abscesses" — lack classical inflammation), pneumonia with pneumatocele formation, eczema, retained primary teeth, skeletal abnormalities. Treatment: prophylactic antibiotics, antifungals.

Table: Primary Immunodeficiency Disorders
DisorderDefectAffected CellsKey FeaturesTreatment
SCIDIL2RG, ADA deficiencyB & T cellsAbsent B and T cell function, severe infections in infancy, "bubble boy"BMT, gene therapy
DiGeorge Syndrome22q11.2 deletionT cells (thymic aplasia)T-cell deficiency, cardiac defects, facial abnormalities, cleft palateThymus transplant
Chediak-HigashiLYST mutationNeutrophilsGiant lysosomal granules, defective phagocytosis, albinism, infectionsBMT
CGDNADPH oxidase defectPhagocytesNo ROS, catalase+ infections, granulomas, NBT test negativeIFN-γ, antibiotics, BMT
Hyper-IgE (Job)STAT3 mutationNeutrophils, T cellsHigh IgE, cold abscesses, eczema, pneumatoceles, retained teethProphylactic antibiotics
NEET Key — Immunodeficiency Mnemonics
SCID — "Severe Combined" = both B and T cells missing. DiGeorge — "D" for deletion 22q11 and "D" for defective thymus. CGD — "G" for granuloma and "G" for glucose (NADPH oxidase uses NADPH from pentose phosphate pathway). Hyper-IgE — "Job" syndrome — Job suffered boils (skin abscesses).
Example 2G — Immunodeficiency
The NBT test is used to diagnose which immunodeficiency disorder?

a) SCID   b) DiGeorge syndrome   c) Chronic Granulomatous Disease   d) Hyper-IgE syndrome
Solution: Option (c). The Nitroblue Tetrazolium (NBT) test diagnoses Chronic Granulomatous Disease (CGD). In CGD, phagocytes cannot produce ROS due to NADPH oxidase defect. NBT dye remains yellow (normal cells reduce it to blue/purple formazan).

AIDS (Acquired Immunodeficiency Syndrome)

Caused by HIV (Human Immunodeficiency Virus) — a retrovirus (RNA virus with reverse transcriptase). HIV infects and destroys Helper T cells (CD4+ T cells), weakening the immune system. Transmission: Sexual contact (most common), Blood transfusion, Sharing needles, Mother-to-child (vertical transmission). Not transmitted: Handshake, sharing utensils, mosquito bites, hugging. Symptoms: Flu-like initial stage (2-6 weeks), asymptomatic latency (8-10 years), then AIDS (opportunistic infections — TB, Pneumocystis pneumonia, Kaposi's sarcoma, dementia). Diagnosis: ELISA (screening), Western blot (confirmatory). Treatment: HAART (Highly Active Antiretroviral Therapy) — combination of drugs including Reverse transcriptase inhibitors (AZT, nevirapine), Protease inhibitors, Integrase inhibitors. No cure yet, but can be managed. Prevention: Safe sex (condoms), sterile needles, blood screening, awareness through NACO and WHO programmes.

NEET Key — HIV Timeline
HIV was first reported in 1981 in the USA. In India, the first case was reported in 1986. The virus was isolated by Luc Montagnier (France) and Robert Gallo (USA). World AIDS Day: December 1st. HIV is a retrovirus — it uses reverse transcriptase to convert its RNA into DNA, which integrates into the host genome.
Example 2B — AIDS
The enzyme used by HIV to convert its RNA into DNA is:

a) DNA polymerase   b) RNA polymerase   c) Reverse transcriptase   d) Integrase
Solution: Option (c). HIV is a retrovirus — it carries reverse transcriptase that converts viral RNA into DNA, which then integrates into the host genome. Integrase helps in integration but reverse transcriptase performs the RNA→DNA conversion.

Innate vs Acquired Immunity

Table: Innate vs Acquired Immunity
FeatureInnate (Non-Specific)Acquired (Specific)
PresencePresent from birthDevelops after exposure
SpecificityNon-specific — defends against all pathogensHighly specific — targets specific antigens
MemoryNo immunological memoryYes — faster response on re-exposure
Response timeImmediate (0-4 hours)Slow (days for primary response)
ComponentsPhysical, physiological, cellular, cytokine barriersB-lymphocytes (humoral), T-lymphocytes (cell-mediated)
Cell typesNeutrophils, macrophages, NK cells, dendritic cellsB cells, T cells (helper, cytotoxic, regulatory)
InheritanceHereditary — passed from parentsNot hereditary — acquired during lifetime
NEET Key — Primary vs Secondary Response
Primary response (first exposure): lag phase of 5-7 days, IgM appears first, followed by IgG, antibody titre is low. Secondary response (second exposure): lag phase of 1-3 days, rapid IgG production, antibody titre is much higher and lasts longer. This is the basis of vaccination — it primes the immune system for a strong secondary response.

Complement System & Interferons

The complement system is a group of ~30 serum proteins that enhance (complement) the ability of antibodies and phagocytes to clear pathogens. It is activated by three pathways: Classical (antibody-dependent), Alternative (spontaneous activation on pathogen surfaces), and Lectin pathway (mannose-binding lectin binds to bacterial carbohydrates). Functions include: opsonisation (coating pathogens for phagocytosis), chemotaxis (attracting immune cells), lysis (forming membrane attack complex that punches holes in bacterial cell walls), and inflammation (triggering mast cell degranulation). Interferons are cytokines (signalling proteins) released by virus-infected cells. They are part of the innate immune system (cytokine barrier). Interferons signal neighbouring uninfected cells to produce antiviral proteins that inhibit viral replication. They also activate NK cells and macrophages. Types: IFN-α (leukocytes), IFN-β (fibroblasts), IFN-γ (T cells and NK cells). Interferon therapy is used in the treatment of hepatitis B, hepatitis C, multiple sclerosis, and certain cancers. Interferons were discovered by Isaacs and Lindenmann (1957).

Example 1D — Interferons
Interferons are produced in response to which type of infection?

a) Bacterial   b) Fungal   c) Viral   d) Protozoan
Solution: Option (c). Interferons are produced by virus-infected cells as part of the innate immune response. They signal nearby cells to produce antiviral proteins, creating an antiviral state. They are classified as cytokine barriers in the innate immune system.

Monoclonal Antibodies (mAbs)

Monoclonal antibodies are identical antibodies produced by a single clone of B-lymphocytes that recognise the same specific epitope on an antigen. They are produced using hybridoma technology, developed by K—hler and Milstein (1975, Nobel Prize 1984).

Production (Hybridoma Technology): (1) A mouse is immunised with a specific antigen. (2) B-lymphocytes producing antibodies against the antigen are isolated from the mouse's spleen. (3) These B cells are fused with myeloma cells (immortalised plasma cell tumour cells) using polyethylene glycol (PEG) or electrical fusion. (4) The fused cells (hybridomas) are cultured in HAT medium (Hypoxanthine-Aminopterin-Thymidine) — unfused B cells die (short-lived), unfused myeloma cells die (HGPRT-deficient, killed by aminopterin). Only hybridomas survive. (5) Hybridomas are screened for desired antibody production and cloned. (6) Selected clones produce large quantities of monoclonal antibodies. mAbs can be chimeric (mouse variable + human constant) or humanised (only CDRs from mouse) to reduce immunogenicity.

Applications: (1) Diagnosis — ELISA tests, pregnancy tests (detect hCG), blood typing, detection of hormones and pathogens. (2) Therapy — Cancer (rituximab for B-cell lymphomas, trastuzumab/Herceptin for HER2+ breast cancer), autoimmune diseases (infliximab for RA), transplant rejection (muromonab-CD3, basiliximab), infectious diseases (palivizumab for RSV), cardiovascular (abciximab). (3) Targeted drug delivery — antibody-drug conjugates (ADCs) like trastuzumab emtansine. (4) Immunoassay — pregnancy test uses mAbs against hCG. When hCG in urine binds to immobilised anti-hCG antibodies coloured with gold particles, a visible line appears.

Examples of therapeutic mAbs: Rituximab (anti-CD20 — B-cell lymphoma, RA), Trastuzumab (anti-HER2 — breast cancer), Infliximab (anti-TNF-α — RA, Crohn's), Adalimumab (anti-TNF-α — RA, psoriasis), Bevacizumab (anti-VEGF — colorectal cancer, inhibits angiogenesis), Pembrolizumab (anti-PD-1 — checkpoint inhibitor). mAb naming suffixes: -omab = mouse, -ximab = chimeric, -zumab = humanised, -umab = fully human.

Table: Therapeutic Monoclonal Antibodies
mAb (Brand)TargetDiseaseType
Rituximab (Rituxan)CD20 on B cellsNon-Hodgkin lymphoma, RAChimeric
Trastuzumab (Herceptin)HER2 receptorHER2+ breast cancerHumanised
Infliximab (Remicade)TNF-αRA, Crohn's diseaseChimeric
Bevacizumab (Avastin)VEGFColorectal cancerHumanised
Pembrolizumab (Keytruda)PD-1Multiple cancersHumanised
Abciximab (ReoPro)GPIIb/IIIaAngioplasty (anti-clot)Chimeric
Palivizumab (Synagis)RSV F proteinRSV prophylaxis in infantsHumanised
NEET Key — Monoclonal Antibody Naming
Suffix tells source: -omab = mouse (100% mouse — can cause HAMA response), -ximab = chimeric (mouse V + human C — ~25% mouse), -zumab = humanised (only CDRs from mouse — ~5% mouse), -umab = fully human (0% mouse). Prefix often indicates target (trastu- for cancer, inflix- for inflammation).
Example 2H — Monoclonal Antibodies
Which cell line is fused with B-lymphocytes to produce hybridomas in monoclonal antibody technology?

a) Fibroblasts   b) Myeloma cells   c) Stem cells   d) T-lymphocytes
Solution: Option (b). Myeloma cells (immortal plasma cell tumour cells) are fused with antibody-producing B cells. The resulting hybridomas combine the immortality of myeloma cells with the antibody-producing ability of B cells. HAT medium selects only successfully fused hybridomas.

ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA is a sensitive immunological test to detect and quantify antigens or antibodies using enzyme-labelled reagents. The enzyme converts a colourless substrate to a coloured product, measured spectrophotometrically. Developed by Engvall and Perlmann (1971).

Principle: An antigen-antibody reaction is detected by an enzyme conjugated to one reactant. The enzyme catalyses a substrate reaction producing a measurable colour change — intensity proportional to the amount of antigen/antibody.

Types of ELISA:

Direct ELISA: Antigen is immobilised on a microtitre plate. Enzyme-labelled primary antibody binds directly to the antigen. Colour proportional to antigen. Used to detect antigen in sample.

Indirect ELISA: Antigen is immobilised. Unlabelled primary antibody (patient serum) binds. Enzyme-labelled secondary antibody (anti-human IgG) binds the primary. Colour proportional to primary antibody present. Used for HIV screening — detects anti-HIV antibodies in patient serum.

Sandwich ELISA: Capture antibody is immobilised. Sample antigen binds to capture antibody. Enzyme-labelled detection antibody (against a different epitope) binds the captured antigen. Highly specific (two antibodies, two epitopes). Used for pregnancy test (hCG), cytokines.

Competitive ELISA: Antigen in sample competes with labelled antigen for limited antibody. More antigen → less labelled antigen binds → weaker colour. Inverse relationship. Used for small molecules (haptens, drugs, hormones).

Steps in Indirect ELISA (HIV diagnosis): (1) Coating: HIV antigens adsorbed onto microtitre wells. (2) Blocking: Unbound sites blocked with BSA to prevent non-specific binding. (3) Washing: Remove excess blocking agent. (4) Primary antibody: Patient serum added — anti-HIV antibodies bind immobilised antigens. (5) Washing: Unbound antibodies removed. (6) Secondary antibody: Enzyme-labelled anti-human IgG added — binds patient antibodies. (7) Washing: Unbound conjugate removed. (8) Substrate: Enzyme substrate (TMB for HRP) added — colour develops if positive (blue → yellow on stop). (9) Reading: Absorbance at 450 nm. ELISA is a screening test for HIV — positive results confirmed by Western blot.

Applications: HIV screening (indirect ELISA), Pregnancy test (sandwich ELISA for hCG), Food allergen detection, Drug monitoring, Hormone assays (thyroid, cortisol), Autoantibody detection (ANA in SLE), Plant virus detection, GMO detection, Cytokine measurement. ELISA is highly sensitive (picogram to nanogram quantities), quantitative, and automatable.

Table: Types of ELISA — Comparison
TypeImmobilisedDetectedSignal vs AnalyteTypical Application
Direct ELISAAntigen (sample)AntigenDirectly proportionalLarge antigen detection
Indirect ELISAAntigen (known)Antibody in serumDirectly proportionalHIV screening, antibody detection
Sandwich ELISACapture antibodyAntigenDirectly proportionalhCG (pregnancy), cytokines, hormones
Competitive ELISAAntibody (or antigen)Small antigens/haptensInversely proportionalDrug monitoring, steroid hormones
NEET Key — ELISA Steps Mnemonic
"C-B-W-A-W-S-W-R" — Coating, Blocking, Wash, Antibody (primary), Wash, Secondary antibody (conjugate), Wash, Read. In Indirect ELISA (HIV test), plate is coated with HIV antigens; patient anti-HIV antibodies are detected using enzyme-labelled anti-human IgG. Positive result requires Western blot confirmation.
Example 2I — ELISA
In an indirect ELISA for HIV diagnosis, what is immobilised on the microtitre plate?

a) Patient antibodies   b) HIV antigens   c) Enzyme-labelled antibodies   d) HIV virus particles
Solution: Option (b). In indirect ELISA for HIV, the plate is coated with HIV antigens (viral proteins). Patient serum is added — anti-HIV antibodies bind to immobilised antigens. An enzyme-labelled anti-human IgG secondary antibody detects bound patient antibodies.
Example 2J — ELISA Types
Which type of ELISA gives colour intensity inversely proportional to the amount of antigen?

a) Direct ELISA   b) Indirect ELISA   c) Sandwich ELISA   d) Competitive ELISA
Solution: Option (d). In competitive ELISA, antigen in the sample competes with labelled antigen for limited antibody binding. More sample antigen → less labelled antigen binds → weaker colour. Direct, indirect, and sandwich ELISAs give colour directly proportional to the analyte.

Vaccines & Immunisation Schedule

Table: Important Vaccines in India's Immunisation Programme
VaccineDiseaseTypeSchedule (as per National Immunisation Schedule)
BCGTuberculosisLive attenuatedAt birth (or as soon as possible till 1 year)
OPV (Oral Polio Vaccine)PoliomyelitisLive attenuated (oral)At birth, 6, 10, 14 weeks + booster at 16-24 months
IPV (Inactivated Polio Vaccine)PoliomyelitisInactivated (injected)At 6 and 14 weeks
DPT (Diphtheria, Pertussis, Tetanus)Diphtheria, Whooping cough, TetanusToxoid/Inactivated6, 10, 14 weeks + boosters at 16-24 months and 5-6 years
Measles vaccineMeaslesLive attenuated9-12 months + booster at 16-24 months (MMR)
MMR (Measles, Mumps, Rubella)Measles, Mumps, RubellaLive attenuated9-12 months + booster at 16-24 months
Hepatitis BHepatitis BRecombinantAt birth (within 24 hours), 6, 10, 14 weeks
TT (Tetanus Toxoid)TetanusToxoid10 years + 2 doses for pregnant women
Hib (Haemophilus influenzae type b)Meningitis, PneumoniaConjugate6, 10, 14 weeks
RotavirusDiarrhoea (Rotavirus)Live attenuated6, 10, 14 weeks (oral)
PCV (Pneumococcal Conjugate)PneumoniaConjugate6, 14 weeks + booster at 9 months
Vaccine Types for NEET
Live attenuated: weakened live pathogen (BCG, OPV, MMR, Rotavirus). Inactivated/Killed: dead pathogen (IPV, Rabies vaccine). Toxoid: inactivated toxin (DPT, TT). Recombinant: produced by genetic engineering (Hepatitis B, HPV). Conjugate: polysaccharide linked to carrier protein (Hib, PCV). mRNA vaccines: deliver mRNA encoding antigen (COVID-19 vaccines from Pfizer, Moderna) — a new technology.

Vaccine Types — Detailed Mechanisms

Vaccines work by exposing the immune system to an antigen in a safe form, generating immunological memory. Different vaccine platforms use different strategies to present antigens to the immune system:

Live Attenuated Vaccines: Contain a weakened (attenuated) form of the live pathogen that cannot cause disease in immunocompetent individuals. Attenuation is achieved by passaging the pathogen through non-human cells or animals until it loses virulence genes. Mechanism: The vaccine strain replicates in the host (limited replication), stimulating both humoral and cell-mediated immunity without causing disease. Advantages: Strong, long-lasting immunity (often lifelong with 1-2 doses), activates both B and T cells. Disadvantages: Cannot be given to immunocompromised individuals, requires cold chain, risk of reversion to virulence (very rare). Examples: BCG (TB), OPV (polio), MMR (measles, mumps, rubella), Rotavirus, Yellow fever, Varicella (chickenpox).

Inactivated/Killed Vaccines: Contain whole pathogens killed by heat, chemicals (formaldehyde, β-propiolactone), or radiation. Mechanism: The inactivated pathogen cannot replicate but intact surface antigens are still recognised. Primarily elicits humoral immunity (antibody response). Advantages: Safe for immunocompromised individuals, cannot revert to virulence, more stable. Disadvantages: Weaker immune response — requires multiple doses (3-4) and boosters, mainly antibody-mediated. Examples: IPV (polio), Rabies, Hepatitis A, Influenza (injected), Pertussis (whole-cell).

Toxoid Vaccines: Contain inactivated toxins (toxoids) produced by bacteria. Treated with formaldehyde to destroy toxicity while retaining immunogenicity. Mechanism: Immune system produces antitoxin antibodies that neutralise the bacterial toxin. Advantages: Safe, stable, induces strong antibody response. Disadvantages: Requires boosters, weak cellular immunity. Examples: Diphtheria toxoid (DPT), Tetanus toxoid (TT).

Recombinant/Subunit Vaccines: Contain specific antigens produced by genetic engineering. Mechanism: Only the immunogenic component is presented — no infectious material. Advantages: Very safe, can be given to immunocompromised, precisely defined, fewer side effects. Disadvantages: Requires adjuvants, often needs multiple doses. Examples: Hepatitis B (HBsAg in yeast), HPV (virus-like particles — Gardasil, Cervarix), Acellular pertussis.

Conjugate Vaccines: Polysaccharide antigens linked to a carrier protein to make them immunogenic in infants. Mechanism: Pure polysaccharides are T-independent antigens — weak response without memory in children under 2. Conjugation to a carrier protein (tetanus toxoid, CRM197) makes them T-dependent, generating strong antibody responses and memory. Advantages: Protective in infants, induces memory, herd immunity. Examples: Hib, PCV13 (pneumococcal), MenACWY (meningococcal), Typhoid conjugate vaccine.

mRNA Vaccines: Contain synthetic mRNA encoding the target antigen, encapsulated in lipid nanoparticles. Mechanism: mRNA is taken up by host cells and translated into antigen protein by host ribosomes. The antigen is presented on MHC molecules, stimulating both humoral and cell-mediated immunity. mRNA does not enter the nucleus or integrate into host genome. Advantages: Rapid development and manufacturing, safe, induces both B and T cell responses. Disadvantages: Requires ultra-cold storage (-20°C to -80°C), reactogenicity. Examples: Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccines.

Viral Vector Vaccines: Use a harmless virus (adenovirus, modified vaccinia Ankara) as a vector to deliver genetic material encoding the target antigen. Mechanism: The viral vector enters host cells and expresses the target antigen. Antigen is presented on MHC molecules, stimulating strong T cell and antibody responses. The vector is replication-defective. Advantages: Strong cellular and humoral immunity, single dose may suffice, stable at fridge temperatures (some). Disadvantages: Pre-existing immunity to vector can reduce efficacy. Examples: Oxford-AstraZeneca (ChAdOx1-S), Johnson & Johnson (Ad26.COV2.S) for COVID-19; Ervebo (Ebola — VSV vector).

Table: Comparison of Vaccine Types
Vaccine TypeContentImmune ResponseDoses RequiredExamples
Live AttenuatedLive, weakened pathogenHumoral + Cellular (strong)1-2BCG, OPV, MMR, Rotavirus
Inactivated/KilledDead pathogenPrimarily humoral (moderate)3-4 + boostersIPV, Rabies, Hepatitis A
ToxoidInactivated toxinHumoral (antitoxin)3 + boostersDPT, TT
Recombinant/SubunitSpecific antigen(s)Humoral + some cellular2-3 + boosterHepatitis B, HPV
ConjugatePolysaccharide + carrier proteinHumoral (T-dependent, strong)3-4 + boosterHib, PCV13, MenACWY
mRNAmRNA encoding antigenHumoral + Cellular (strong)2 + boostersPfizer, Moderna COVID-19
Viral VectorRecombinant viral DNAHumoral + Cellular (strong)1-2AstraZeneca, J&J, Ervebo
NEET Key — Vaccine Types Memory Aid
"LITRCMV" — Live attenuated, Inactivated, Toxoid, Recombinant, Conjugate, mRNA, Viral vector. For NEET focus: BCG, OPV, MMR (live attenuated); IPV, Rabies (inactivated); DPT, TT (toxoid); Hepatitis B (recombinant); Hib, PCV (conjugate). Know which type each major vaccine belongs to.
Example 2K — Vaccine Types
The Hepatitis B vaccine is produced by recombinant DNA technology. Which organism is used to produce the HBsAg antigen?

a) E. coli   b) Saccharomyces cerevisiae   c) Aspergillus niger   d) Penicillium notatum
Solution: Option (b). The Hepatitis B vaccine is produced by expressing the HBsAg (hepatitis B surface antigen) gene in Saccharomyces cerevisiae (baker's yeast). The yeast produces large quantities of the antigen, which is purified and used as the vaccine. This was the first recombinant vaccine approved for human use.

Cancer

Uncontrolled cell division caused by genetic mutations in oncogenes (promote cell division — when mutated, become hyperactive) and tumour suppressor genes (e.g., p53 — normally prevent cancer; when mutated, lose function). Cancer-causing genes (oncogenes) were discovered by Bishop and Varmus (Nobel Prize). Cancer results from accumulation of multiple mutations over time, not a single change.

Table: Benign vs Malignant Tumours
FeatureBenign TumourMalignant Tumour
Growth rateSlowRapid
InvasivenessNon-invasive (localised)Invasive — invades surrounding tissues
Spread (metastasis)Does not metastasiseMetastasises via blood/lymph to distant sites
EncapsulationEncapsulated (well-defined boundary)Not encapsulated (irregular boundary)
Cell morphologyResembles normal cellsAnaplastic (abnormal, pleomorphic)
RecurrenceRare after removalCommon — may recur after treatment
Danger to lifeRarely life-threateningLife-threatening if untreated
ExampleUterine fibroids, skin molesLung carcinoma, breast cancer, leukaemia

Carcinogens: Physical (UV, X-rays, gamma rays — ionising radiation damages DNA), Chemical (tobacco smoke containing benzopyrene, asbestos, aflatoxins from fungus on peanuts — potent liver carcinogens), Biological (oncogenic viruses — HPV causes cervical cancer, Hepatitis B and C cause liver cancer, EBV causes Burkitt's lymphoma). Diagnosis: Biopsy (tissue examination), CT/MRI scans, X-rays, mammography (breast cancer), Pap smear (cervical cancer), endoscopy, blood tests (tumour markers like PSA for prostate cancer). Treatment: Surgery (removal of tumour), Radiation therapy (radiotherapy — high-energy radiation kills cancer cells), Chemotherapy (drugs that target rapidly dividing cells — side effects: hair loss, nausea, immunosuppression), Immunotherapy (monoclonal antibodies like rituximab, checkpoint inhibitors like pembrolizumab), Targeted therapy (imatinib/Gleevec for Chronic Myeloid Leukaemia — targets BCR-ABL fusion protein). Cancer warning signs (CAUTION): Change in bowel/bladder habits, A sore that does not heal, Unusual bleeding/discharge, Thickening/lump in breast or elsewhere, Indigestion/difficulty swallowing, Obvious change in wart/mole, Nagging cough/hoarseness.

NEET Key — Cancer Terms
(1) Oncogenes — genes that promote cell division (ras, myc). When mutated or overexpressed, they become cancer-causing. (2) Tumour suppressor genes — genes that inhibit cell division (p53, Rb, BRCA1/2). Loss of function leads to cancer. p53 is called the "guardian of the genome" — it halts cell cycle if DNA is damaged and triggers apoptosis if damage is irreparable. (3) Carcinoma — cancer of epithelial cells (most common). Sarcoma — connective tissue. Leukaemia — blood cancer. Lymphoma — lymphatic tissue. (4) Metastasis — spread of cancer cells through blood/lymph to form secondary tumours — responsible for most cancer deaths.
Example 2F — Cancer Genetics
Which gene is known as the 'guardian of the genome'?

a) ras   b) myc   c) p53   d) BRCA1
Solution: Option (c). The p53 tumour suppressor gene is known as the guardian of the genome. It prevents cancer by halting the cell cycle when DNA is damaged, allowing repair. If damage is severe, it triggers programmed cell death (apoptosis). Mutations in p53 are found in over 50% of human cancers.

Cancer Biology — Oncogenes vs Tumour Suppressor Genes

Cancer arises from the accumulation of mutations in two broad classes of genes: proto-oncogenes (which promote cell growth) and tumour suppressor genes (which inhibit cell growth). A single mutation is rarely sufficient — multiple "hits" are required (Knudson's two-hit hypothesis for retinoblastoma).

Table: Oncogenes vs Tumour Suppressor Genes
FeatureProto-oncogenesTumour Suppressor Genes
Normal functionPromote cell growth and division (growth factors, receptors, signal transducers, transcription factors)Inhibit cell growth, repair DNA damage, induce apoptosis, regulate cell cycle checkpoints
Effect of mutationGain-of-function → activated oncogene → uncontrolled proliferationLoss-of-function (both alleles mutated) → loss of growth inhibition
Inheritance patternDominant at cellular level (one mutated allele sufficient)Recessive at cellular level (both alleles must be mutated — "two-hit hypothesis")
Mechanism of activationPoint mutation (ras), Gene amplification (myc), Chromosomal translocation (BCR-ABL in CML)Deletion, point mutation (loss of function), Epigenetic silencing (promoter methylation)
Examplesras (GTPase — mutated in ~30% of cancers), myc (transcription factor — amplified in Burkitt's lymphoma), HER2/neu (receptor tyrosine kinase — amplified in breast cancer), BCR-ABL (fusion protein in CML), BRAF (kinase — mutated in melanoma)p53/TP53 (guardian of the genome — mutated in >50% of cancers), Rb (retinoblastoma — cell cycle regulator), BRCA1/2 (DNA repair — breast/ovarian cancer), APC (colon cancer), PTEN (PI3K pathway inhibitor), VHL (von Hippel-Lindau)
Knudson's two-hitNot applicable (single hit sufficient)Both alleles must be inactivated (e.g., Rb gene — first hit inherited or somatic, second hit somatic)
Therapeutic targetingTargeted inhibitors (imatinib for BCR-ABL, gefitinib for EGFR, vemurafenib for BRAF V600E, trastuzumab for HER2)Harder to target — synthetic lethality approaches (PARP inhibitors for BRCA-mutated cancers)

Cancer Staging and Grading

Cancer staging describes the extent of cancer spread. The most commonly used system is the TNM system (Tumour, Node, Metastasis): T describes the size of the primary tumour (T0-T4), N describes lymph node involvement (N0-N3), M describes distant metastasis (M0 or M1). Stage I: localised cancer. Stage II-III: locally advanced with lymph node involvement. Stage IV: metastatic cancer (spread to distant organs). Staging guides treatment decisions and predicts prognosis.

Cancer grading describes how much tumour cells resemble normal cells (differentiation). Grade 1 (well-differentiated) — cells look relatively normal, grow slowly, better prognosis. Grade 3 (poorly differentiated/anaplastic) — cells look abnormal, grow aggressively. Grade 4 (undifferentiated) — cells bear no resemblance to normal tissue.

Targeted Therapy and Immunotherapy in Cancer

Traditional chemotherapy targets all rapidly dividing cells, causing significant side effects. Targeted therapy uses drugs that specifically target molecular abnormalities in cancer cells:

Imatinib (Gleevec): The first successful targeted cancer drug. Targets the BCR-ABL fusion protein — a constitutively active tyrosine kinase produced by the Philadelphia chromosome (t(9;22) translocation) in Chronic Myeloid Leukaemia (CML). Imatinib binds to the ATP-binding pocket of BCR-ABL, inhibiting its activity. Treated CML patients have near-normal life expectancy. Also targets c-KIT (for GIST).

Gefitinib (Iressa) and Erlotinib (Tarceva): Target EGFR tyrosine kinase — mutated and overactive in some non-small cell lung cancers (EGFR-mutated NSCLC). These inhibitors block signalling pathways driving cancer cell proliferation.

Trastuzumab (Herceptin): A monoclonal antibody targeting HER2/neu receptor — overexpressed in ~20% of breast cancers (HER2-positive). Blocks receptor signalling and triggers antibody-dependent cell-mediated cytotoxicity (ADCC).

Vemurafenib: Targets the BRAF V600E mutation — found in ~50% of melanomas. BRAF is a kinase in the MAPK/ERK signalling pathway. The V600E mutation makes BRAF constitutively active.

Immunotherapy (Checkpoint Inhibitors): Cancer cells evade the immune system by expressing inhibitory molecules that turn off T cells. PD-1/PD-L1 pathway: Cancer cells express PD-L1 which binds to PD-1 on T cells, suppressing T cell activity. Anti-PD-1 antibodies (pembrolizumab/Keytruda, nivolumab/Opdivo) block this interaction, restoring T cell killing. Approved for melanoma, NSCLC, kidney cancer, Hodgkin lymphoma. CTLA-4 pathway: Ipilimumab (Yervoy) blocks CTLA-4 on T cells, enhancing T cell activation. Used for melanoma. Checkpoint inhibitors can cause immune-related adverse events (irAEs) — colitis, pneumonitis, dermatitis, endocrinopathies. CAR-T cell therapy: Patient's own T cells are genetically engineered to express a chimeric antigen receptor (CAR) targeting cancer cells. Approved for B-cell ALL (tisagenlecleucel/Kymriah — anti-CD19) and DLBCL (axicabtagene ciloleucel/Yescarta).

Table: Targeted Cancer Therapies
DrugTargetCancer TypeMechanism
Imatinib (Gleevec)BCR-ABL, c-KITCML, GISTTyrosine kinase inhibitor
Gefitinib (Iressa)EGFRNSCLC (EGFR-mutated)EGFR inhibitor
Trastuzumab (Herceptin)HER2/neuHER2+ breast cancerMonoclonal antibody + ADCC
VemurafenibBRAF V600EMelanomaKinase inhibitor
Pembrolizumab (Keytruda)PD-1Melanoma, NSCLC, many othersCheckpoint inhibitor
Ipilimumab (Yervoy)CTLA-4MelanomaCheckpoint inhibitor
Olaparib (Lynparza)PARPBRCA-mutated ovarian/breast cancerPARP inhibitor (synthetic lethality)
NEET Key — Cancer Therapy Highlights
(1) Chemotherapy is non-specific — kills all rapidly dividing cells. (2) Targeted therapy (Imatinib, Gefitinib) targets specific molecules — fewer side effects. (3) Monoclonal antibodies (Trastuzumab, Rituximab) are also targeted therapy. (4) Checkpoint inhibitors (Pembrolizumab, Ipilimumab) reactivate the immune system against cancer. (5) Imatinib was the first targeted cancer therapy — revolutionised CML treatment. (6) Philadelphia chromosome t(9;22) creates BCR-ABL fusion gene in CML — targeted by Imatinib.
Example 2L — Cancer Therapy
Imatinib (Gleevec) is used to treat Chronic Myeloid Leukaemia by specifically targeting which fusion protein?

a) p53   b) BCR-ABL   c) RAS   d) HER2
Solution: Option (b). Imatinib targets the BCR-ABL fusion protein, a constitutively active tyrosine kinase produced by the Philadelphia chromosome translocation t(9;22). This was the first targeted cancer therapy and transformed CML from a fatal disease to a manageable chronic condition.
Example 2M — Checkpoint Inhibitors
Pembrolizumab (Keytruda) is an immune checkpoint inhibitor that targets which receptor on T cells?

a) CTLA-4   b) PD-1   c) CD20   d) HER2
Solution: Option (b). Pembrolizumab is an anti-PD-1 monoclonal antibody. It blocks the PD-1/PD-L1 interaction, preventing cancer cells from suppressing T cell activity and reactivating the anti-tumour immune response.

Transplantation Immunology

Transplantation is the transfer of cells, tissues, or organs from one site to another. The immune system recognises transplanted tissues as foreign (unless perfectly matched), leading to graft rejection. The major histocompatibility complex (MHC) — called HLA (Human Leukocyte Antigen) in humans — is the primary determinant of transplant compatibility.

Types of grafts:

Autograft: Transplant from one site to another in the same individual (e.g., skin grafts in burn patients, bone grafts, saphenous vein grafts in coronary bypass). No immune rejection — recognised as "self".

Isograft (Syngeneic graft): Transplant between genetically identical individuals (identical twins). No immune rejection — genetically identical.

Allograft (Homograft): Transplant between genetically different individuals of the same species (e.g., kidney, heart, liver transplant). Most common type. Recipient's immune system recognises donor HLA molecules as foreign → graft rejection. Requires HLA matching and immunosuppression.

Xenograft (Heterograft): Transplant between different species (e.g., pig heart valves to humans). Faces hyperacute rejection due to pre-existing antibodies against galactose-α-1,3-galactose epitopes on pig tissues. Genetically modified pigs are being developed to overcome this.

Graft rejection mechanisms: Hyperacute rejection: Occurs within minutes to hours — pre-existing antibodies bind to donor endothelial antigens → complement activation → thrombosis. Prevented by ABO matching and cross-matching. Acute rejection (HVGR — Host vs Graft): Occurs within days to weeks — T cell-mediated (CD8+ CTLs) and antibody-mediated attack on the graft. Managed by immunosuppressive drugs. Chronic rejection: Occurs over months to years — fibrosis, vessel occlusion (transplant vasculopathy), gradual graft loss. Difficult to treat.

Graft vs Host Disease (GVHD): Occurs when donor immune cells (in bone marrow or stem cell transplants) recognise recipient tissues as foreign and attack them. Recipient is immunocompromised and cannot reject donor cells. Acute GVHD (within 100 days) affects skin (rash), liver (jaundice), and gut (diarrhoea). Chronic GVHD (after 100 days) resembles autoimmune disease. Prevention: T-cell depletion, immunosuppression (methotrexate, cyclosporine), HLA matching.

Immunosuppression in transplantation: Calcineurin inhibitors: Cyclosporine (from Trichoderma polysporum), Tacrolimus — inhibit T-cell activation by blocking calcineurin → prevent IL-2 production. Antiproliferatives: Azathioprine, Mycophenolate mofetil — block lymphocyte proliferation. Corticosteroids: Prednisolone — broad anti-inflammatory. Antibody-based: Muromonab-CD3 (OKT3 — anti-CD3 mAb), Basiliximab (anti-IL-2 receptor mAb), Anti-thymocyte globulin (ATG). HLA matching focuses on HLA-A, HLA-B, HLA-DR loci. A "full match" (6/6) between siblings gives best outcomes.

HLA System: MHC in humans is located on chromosome 6. Class I HLA (A, B, C) — on all nucleated cells, recognised by CD8+ T cells. Class II HLA (DP, DQ, DR) — on antigen-presenting cells, recognised by CD4+ T cells. High polymorphism of HLA genes makes finding matched unrelated donors challenging. Chance of full siblings sharing identical HLA haplotypes is 25%.

Table: Types of Grafts in Transplantation
Graft TypeDefinitionImmune RejectionExample
AutograftSame individual (self to self)None — recognised as selfSkin graft, bone graft, vein graft
Isograft (Syngeneic)Genetically identical individualsNone — genetically identicalIdentical twin kidney transplant
Allograft (Homograft)Same species, different geneticsYes — HVGR (acute/chronic)Kidney, heart, liver transplant
Xenograft (Heterograft)Different speciesYes — hyperacute rejectionPig heart valves, porcine islets
NEET Key — Graft Types Mnemonic
"A-I-A-X" — Auto (self), Iso (identical), Allo (same species, different), Xeno (different species). Rejection risk increases from A → X. Autografts are never rejected; isografts between identical twins are accepted; allografts require immunosuppression; xenografts face hyperacute rejection due to pre-existing cross-species antibodies.
Example 2N — Transplantation
Graft versus Host Disease (GVHD) is most commonly associated with which type of transplant?

a) Kidney transplant   b) Bone marrow transplant   c) Heart transplant   d) Corneal transplant
Solution: Option (b). GVHD occurs when immunocompetent donor T cells (in the bone marrow graft) recognise the immunocompromised recipient's tissues as foreign and attack them. It is most common in bone marrow (haematopoietic stem cell) transplantation. Solid organ transplants cause HVGR (host vs graft rejection), not GVHD.
Example 2O — Immunosuppressants
Cyclosporine, an immunosuppressant used in organ transplants, acts by inhibiting which process in T cells?

a) IgG synthesis   b) Antigen presentation   c) Calcineurin (IL-2 production)   d) MHC expression
Solution: Option (c). Cyclosporine inhibits calcineurin, a phosphatase that activates the NFAT transcription factor needed for IL-2 gene transcription. By blocking IL-2 production, cyclosporine prevents T cell activation and proliferation. It is produced by the fungus Trichoderma polysporum.

Drugs & Alcohol Abuse

Drug abuse is the harmful use of psychoactive substances. The most commonly abused substances in India: (1) Opioids (heroin, morphine, codeine) — derived from opium poppy (Papaver somniferum). Heroin (brown sugar, smack) is diacetylmorphine — highly addictive, snorted or injected. (2) Cannabinoids — from Cannabis sativa (marijuana, hashish, ganja, charas). THC (tetrahydrocannabinol) is the active compound — affects mood, perception, appetite. (3) Cocaine — from coca plant (Erythroxylum coca) — central nervous system stimulant, highly addictive ("crack" is the freebase form). (4) Hallucinogens — LSD (lysergic acid diethylamide), mescaline (peyote cactus), psilocybin (magic mushrooms) — alter perception and mood. (5) Amphetamines — synthetic stimulants (speed, ecstasy/MDMA). (6) Barbiturates, benzodiazepines — sedatives (tranquillisers). (7) Tobacco — nicotine, tar, carbon monoxide — associated with lung cancer, COPD, cardiovascular disease. (8) Alcohol — legal, but excessive use causes cirrhosis, pancreatitis, dependence.

Dependence: Psychological (craving) and physical (withdrawal symptoms — nausea, tremors, seizures) occur when the substance is stopped. Tolerance: Need for increasing doses to achieve the same effect. Treatment: De-addiction centres (counselling, CBT), pharmacotherapy (methadone for heroin, bupropion for tobacco), 12-step programmes (Narcotics Anonymous), family and community support. The NDPS Act (1985) in India prohibits the manufacture, sale, and use of narcotic drugs and psychotropic substances except for medical purposes.

Opioids: Morphine (from opium poppy — Papaver somniferum) — used medically as a potent painkiller (analgesic) but highly addictive. Heroin (smack, diacetylmorphine) — made from morphine, more potent, causes intense euphoria followed by severe depression, physical dependence develops within weeks. Withdrawal: severe pain, diarrhoea, vomiting, muscle cramps. Cannabinoids: Marijuana/bhang/ganja/charas/hashish — all from Cannabis sativa. Active compound: THC (delta-9-tetrahydrocannabinol). Causes altered perception, increased heart rate, impaired coordination, and in chronic users, reduced motivation (amotivational syndrome). Cocaine: From leaves of Erythroxylum coca. Blocks dopamine reuptake in the brain's reward pathway, producing intense euphoria followed by severe depression. Crack cocaine is the smokable, more addictive form. Withdrawal: severe depression, fatigue, paranoia. Hallucinogens: LSD (Lysergic Acid Diethylamide — from ergot fungus, discovered by Albert Hofmann) — alters sensory perception, causes hallucinations even in tiny doses (micrograms). Mescaline (from peyote cactus), Psilocybin (from magic mushrooms). Barbiturates and Benzodiazepines: CNS depressants used as sedatives and tranquillisers — highly addictive, dangerous when combined with alcohol. Tobacco: Contains nicotine (addictive stimulant) — causes lung cancer (leading cause of cancer deaths worldwide), COPD, emphysema, heart disease, stroke, oral cancer, and pregnancy complications. Tobacco kills nearly 8 million people annually worldwide. Alcohol: CNS depressant — initially reduces inhibition, then impairs coordination, judgement, and consciousness. Long-term effects: liver cirrhosis (scarring of liver), hepatitis, pancreatitis, brain damage (Wernicke-Korsakoff syndrome), heart disease, addiction. Foetal alcohol syndrome in children of mothers who drink during pregnancy.

Table: Major Drugs of Abuse
CategorySourceExamplesEffects
OpioidsPapaver somniferumMorphine, Heroin, CodeinePain relief, euphoria, addiction, respiratory depression
CannabinoidsCannabis sativaMarijuana, Hashish, Ganja, CharasAltered perception, increased heart rate, impaired memory
CocaineErythroxylum cocaCocaine, Crack cocaineIntense euphoria, then depression, paranoia, cardiac risk
HallucinogensErgot fungus, cactus, mushroomsLSD, Mescaline, PsilocybinAltered sensory perception, hallucinations, psychosis
BarbituratesSyntheticPhenobarbital, PentobarbitalCNS depression, sedation, addiction, overdose risk
NicotineNicotiana tabacumCigarettes, chewing tobacco, gutkaStimulant, addiction, lung cancer, heart disease, COPD
AlcoholFermentationEthanol in beveragesCNS depression, liver cirrhosis, brain damage, addiction

Prevention of drug abuse: Education about harmful effects, counselling, building self-esteem, healthy recreational alternatives, avoiding peer pressure, parental guidance and communication. Treatment: De-addiction programmes (medical + psychological support), rehabilitation centres, pharmacotherapy (methadone for heroin addiction, nicotine patches for tobacco), and support groups (Alcoholics Anonymous, Narcotics Anonymous). The NDPS Act (1985) in India restricts and regulates drug use, with severe penalties for trafficking. The "Just Say No" campaign and school-based education programmes aim at primary prevention. COTPA (Cigarettes and Other Tobacco Products Act, 2003) prohibits smoking in public places and advertising of tobacco products in India.

NEET Key — Addiction & Dependence
Drug addiction is a chronic, relapsing brain disorder characterised by compulsive drug seeking despite harmful consequences. Physical dependence: body adapts to drug presence → withdrawal symptoms on cessation. Psychological dependence: intense craving, inability to function without the drug. Tolerance: needing higher doses to get the same effect. Adolescence is the most vulnerable period for initiation of drug use due to peer pressure, curiosity, and the developing brain's heightened reward sensitivity.
Example 2 — Immunity
Which antibody is most abundant in serum and crosses the placenta?

a) IgA   b) IgM   c) IgG   d) IgE
Solution: Option (c). IgG is the most abundant immunoglobulin in serum (~75-80%) and is the only antibody that can cross the placenta, providing passive immunity to the foetus.
Example 2C — Vaccination & Eradication
Edward Jenner developed the first vaccine against which disease?

a) Polio   b) Smallpox   c) Rabies   d) Tuberculosis
Solution: Option (b). Edward Jenner (1796) developed the first vaccine against smallpox using cowpox virus. This led to the global eradication of smallpox, declared by WHO in 1979. Louis Pasteur developed the rabies vaccine later.
Example 2D — Drugs
Which plant is the source of morphine used in medicine?

a) Cannabis sativa   b) Papaver somniferum   c) Erythroxylum coca   d) Atropa belladonna
Solution: Option (b). Morphine is obtained from the opium poppy (Papaver somniferum). Cannabis sativa gives cannabinoids (marijuana). Erythroxylum coca gives cocaine. Morphine is used as a potent painkiller but is highly addictive.
NEET Key — Drug Classification
(1) Narcotics/Opiates: Morphine, Heroin — pain relief, euphoria. (2) Cannabinoids: Marijuana, Hashish — altered perception. (3) Stimulants: Cocaine, Amphetamines — increased alertness followed by depression. (4) Hallucinogens: LSD, Mescaline — altered sensory perception. (5) Depressants: Alcohol, Barbiturates — CNS depression. Tobacco (nicotine) is a stimulant with severe health effects including lung cancer and heart disease.
Example 2E — Drug Abuse Prevention
The NDPS Act in India was enacted in which year?

a) 1975   b) 1985   c) 1995   d) 2005
Solution: Option (b). The Narcotic Drugs and Psychotropic Substances (NDPS) Act was enacted in 1985 to regulate drug use and prevent drug abuse in India. It prohibits the production, possession, and sale of narcotic drugs and psychotropic substances except for medical and scientific purposes.
CommunicableDiseasesNon‑communicableDiseasesVaccines &ImmunisationAntibiotics &AntimicrobialsMicrobes in HumanWelfarepreventtreatenablesupportArt. 47: State shall raise nutrition & public healthMechanism: Microbes produce antibiotics, vaccines, probioticsvlymbooq
Human Health Diseases and Microbes in Welfare for Exam Revision — Shows how communicable and non‑communicable diseases link to vaccines, antibiotics and beneficial microbes for human welfare. · Open the full diagram →

Microbes in Human Welfare

Microbes (bacteria, fungi, protozoa, viruses) are not always harmful — they play crucial beneficial roles in human welfare, industry, and the environment.

Microbes in Household Products

Microbes have been used for thousands of years in food preparation, long before the discovery of their existence. Common household products made using microbes:

Curd/Yoghurt: Lactobacillus (bacteria) and Lactobacillus bulgaricus + Streptococcus thermophilus ferment lactose to lactic acid, coagulating milk proteins. Curd can be used to inoculate fresh milk to make more curd (traditional practice). Bread, Idli, Dosa: Saccharomyces cerevisiae (baker's yeast) produces CO2 that causes dough/batter to rise. The ethanol produced evaporates during baking/cooking. Cheese: Penicillium roqueforti gives Roquefort cheese its blue veins and sharp flavour. Penicillium camemberti gives Camembert its soft, creamy texture and white rind. Swiss cheese has large holes caused by Propionibacterium shermanii which produces CO2 during ripening. Vinegar: Acetobacter aceti oxidises ethanol in fermented liquids (wine, cider) to acetic acid. Used as a preservative and condiment. Fermented foods: Soy sauce (fermented by Aspergillus oryzae — koji mould — and Lactobacillus + yeast in brine), Tofu (soybean curd — Mucor species used to ferment soybeans in some varieties), Sauerkraut (cabbage fermented by Leuconostoc and Lactobacillus species in salt brine), Kimchi (Korean fermented vegetables), Natto (fermented soybeans by Bacillus subtilis — rich in vitamin K2), Tempeh (fermented soybeans by Rhizopus oligosporus — a fungus). Pickles (vegetables preserved in brine where natural Lactobacillus fermentation produces acid that preserves them).

NEET Key — Household Microbes Summary
(1) Curd: Lactobacillus (lactic acid). (2) Bread/Idli/Dosa: Saccharomyces cerevisiae (CO₂). (3) Cheese: Penicillium roqueforti (blue cheese), P. camemberti (soft cheese). (4) Vinegar: Acetobacter aceti (acetic acid). (5) Soy sauce: Aspergillus oryzae + Lactobacillus + yeast. (6) Yogurt: L. bulgaricus + S. thermophilus. (7) Toddy: natural fermentation of palm sap by yeast.

Microbes in Industrial Products

Microbes are used in large-scale industrial fermentation to produce a wide range of products valuable to humans. The choice of microbe depends on the desired product and optimal fermentation conditions (temperature, pH, aeration, nutrient availability).

Alcoholic beverages: Saccharomyces cerevisiae (brewer's/baker's yeast) ferments sugars to ethanol and CO2. Wine is made by fermenting grape juice. Beer uses barley malt (sprouted barley grains) fermented by yeast, with hops added for bitterness and flavour. Distilled spirits (whisky, rum, brandy, vodka, gin) are produced by distilling the fermented liquid to concentrate ethanol. In India, Mahua flowers and Toddy (from palm sap) are traditional fermented beverages.

Table: Major Industrial Products from Microbes
ProductMicrobeTypeApplication
PenicillinPenicillium notatumFungusAntibiotic — kills gram-positive bacteria
StreptomycinStreptomyces griseusBacteriumAntibiotic — TB treatment
TetracyclineStreptomyces aureofaciensBacteriumBroad-spectrum antibiotic
ErythromycinStreptomyces erythraeusBacteriumAntibiotic — respiratory infections
Cyclosporin ATrichoderma polysporumFungusImmunosuppressant — organ transplants
StatinsMonascus purpureusYeast/FungusCholesterol-lowering drug
Citric acidAspergillus nigerFungusFood acidulant, preservative
Lactic acidLactobacillus spp.BacteriumFood preservative, plastics
Glutamic acid (MSG)Corynebacterium glutamicumBacteriumFlavour enhancer
Vitamin B12Pseudomonas denitrificansBacteriumVitamin supplement
StreptokinaseStreptococcus spp.BacteriumClot buster — heart attack treatment
LipaseCandida rugosaYeastDetergent additive — removes oily stains
PectinaseAspergillus nigerFungusFruit juice clarification
DextranLeuconostoc mesenteroidesBacteriumBlood plasma substitute
EthanolSaccharomyces cerevisiaeYeastFuel, beverages, solvent
Example 3D — Industrial Products
Cyclosporin A, used as an immunosuppressant in organ transplants, is obtained from:

a) Monascus purpureus   b) Trichoderma polysporum   c) Penicillium notatum   d) Aspergillus niger
Solution: Option (b). Cyclosporin A is produced by the fungus Trichoderma polysporum. It suppresses the immune system to prevent organ rejection in transplant patients. Monascus purpureus produces statins; Penicillium produces penicillin; Aspergillus niger produces citric acid.
Example 3E — Enzymes from Microbes
Which enzyme produced by Streptococcus is used to dissolve blood clots in heart attack patients?

a) Lipase   b) Pectinase   c) Streptokinase   d) Cellulase
Solution: Option (c). Streptokinase, produced by Streptococcus bacteria, is used as a "clot buster" (thrombolytic agent) to dissolve blood clots in myocardial infarction (heart attack) and stroke patients. It activates plasminogen to plasmin, which breaks down fibrin clots.
NEET Key — Antibiotic Discoverers
Penicillin (Fleming, 1928), Streptomycin (Waksman, 1943 — Nobel Prize). Most antibiotics are produced by soil bacteria (Streptomyces genus — actinomycetes). Antibiotics work by: inhibiting cell wall synthesis (penicillin), inhibiting protein synthesis (tetracycline, erythromycin), inhibiting nucleic acid synthesis (quinolones), or disrupting cell membrane (polymyxins). Antibiotic resistance is a growing global health crisis driven by misuse and overuse of antibiotics.

Microbes in Sewage Treatment

Sewage (municipal waste water) contains organic matter, pathogens, and suspended solids that must be removed before the water can be released into natural water bodies. The treatment process involves multiple stages:

Primary treatment: Physical process — sewage is passed through screens and grit chambers to remove large objects (rags, sticks, plastic), then enters sedimentation tanks where suspended solids settle as sludge and oils/grease float to the surface (skimming). Removes about 50-60% of suspended solids.

Secondary treatment (Biological): The effluent from primary treatment enters aeration tanks where air is bubbled through the liquid. Aerobic microbes (bacteria, fungi, protozoa) grow and form flocs (masses of microbes held together by slime layers). These microbes consume organic matter (BOD reduction). After aeration, the mixture enters a settling tank where the microbial flocs settle as activated sludge. Some sludge is recycled to maintain the microbial population in the aeration tank. The remaining sludge is transferred to an anaerobic digester. The clarified effluent (treated water) is disinfected (chlorinated or UV treated) before being released into rivers or reused for irrigation. The activated sludge process reduces BOD (Biochemical Oxygen Demand) by 90-95%.

Sludge treatment: The settled sludge is digested anaerobically by methanogenic bacteria (Methanobacterium) in a closed digester tank. This produces biogas (methane) which can be used as fuel. The remaining digested sludge is used as fertiliser (rich in nutrients). BOD: Amount of oxygen (in mg/L) required by aerobic microbes to decompose organic matter in a water sample over 5 days at 20°C. High BOD = high organic pollution. Clean water has BOD < 5 mg/L; raw sewage has BOD of 200-600 mg/L. BOD is a key parameter for assessing water quality and treatment efficiency.

Example 3F — Sewage Treatment
In sewage treatment, the activated sludge is produced during which stage?

a) Primary treatment   b) Secondary treatment   c) Tertiary treatment   d) Sludge digestion
Solution: Option (b). Activated sludge (microbial flocs) is produced during secondary (biological) treatment in the aeration tank. The flocs consume organic matter and are then settled. Some sludge is recycled to maintain the microbial population.

Microbes in Biogas Production

Biogas is a clean, renewable fuel produced by the anaerobic digestion of organic matter. Composition: Methane (CH4: 50-70%), Carbon dioxide (CO2: 30-40%), Hydrogen (H2: 1-5%), Hydrogen sulphide (H2S: traces). Biogas is produced by the action of methanogenic bacteria (Methanobacterium, Methanococcus, Methanosarcina) — these are archaebacteria found naturally in marshes, swamps, and the gut of ruminant animals (cows, buffaloes).

Biogas plant: A typical biogas plant (e.g., Gobar gas plant) has: (1) Mixing tank — cow dung and water are mixed into a slurry. (2) Digester — a sealed, underground concrete tank where anaerobic digestion occurs. The slurry remains for about 40-50 days. (3) Gas holder — a movable steel or fibreglass dome that collects the biogas produced. (4) Outlet — the spent slurry (rich in nutrients) flows out and is used as fertiliser. (5) Gas pipe — connects to stoves, lamps, or generators. A family-sized plant (2-4 m3 gas/day) requires about 25-50 kg of cow dung daily. Benefits: clean fuel (reduces smoke indoors), fertiliser from slurry, waste disposal, reduces deforestation (less wood burning), and reduces greenhouse gas emissions (methane is captured rather than released from open manure pits).

NEET Key — Biogas Production Conditions
Anaerobic digestion requires: (1) Absence of oxygen — digester is sealed. (2) Temperature: 30-40°C (mesophilic) or 50-60°C (thermophilic). (3) pH: 6.5-7.5 (neutral). (4) Carbon:Nitrogen ratio: 20-30:1. Methanogens are highly sensitive to oxygen — even trace amounts inhibit their activity. Cattle dung is the most common feedstock because it contains the right mix of nutrients and naturally occurring methanogens from the cow's rumen.

Microbes as Biocontrol Agents

Using natural predators/pathogens to control pests, avoiding chemical pesticides. Bacillus thuringiensis (Bt): Produces a toxin (Bt toxin) that kills insect larvae (used in Bt cotton — a GM crop, but the lesson here is the natural microbe itself). Trichoderma: A fungus used as a biocontrol agent against soil-borne plant pathogens. Nucleopolyhedrovirus (NPV): A virus that infects insects; species-specific, does not harm non-target organisms. Ladybird beetles and Dragonflies are also used but are not microbes — they are biological control agents in general. The concept of biological control is ecologically sustainable and avoids the environmental damage caused by chemical pesticides.

Microbes as Biofertilisers

Living microorganisms that enrich soil nutrients. Rhizobium: Symbiotic nitrogen-fixing bacteria in root nodules of legumes (converts atmospheric N2 to usable forms). Azospirillum and Azotobacter: Free-living nitrogen-fixing bacteria (Azotobacter in soil, Azospirillum associated with grass roots). Cyanobacteria (Blue-green algae): Nostoc, Anabaena, Oscillatoria — fix atmospheric nitrogen in waterlogged rice paddies. Azolla (a water fern) has Anabaena azollae in its leaves and is used as a green manure in rice cultivation. Mycorrhiza (fungus-root association): Helps in phosphorus uptake from soil. Biofertilisers are cost-effective, eco-friendly, and reduce the need for chemical fertilisers.

Biocontrol vs Biofertilisers — Comparison

Table: Biocontrol Agents vs Biofertilisers
FeatureBiocontrol AgentsBiofertilisers
FunctionControl pests and pathogensEnrich soil nutrients
ExamplesBt (Bacillus thuringiensis), Trichoderma, NPVRhizobium, Azospirillum, Azotobacter, Cyanobacteria, Mycorrhiza
TargetInsect larvae, soil pathogensPlants (enhance nutrient uptake)
MechanismToxin production, parasitism, competitionNitrogen fixation, phosphate solubilisation, nutrient mobilisation
Environmental impactReduces chemical pesticide useReduces chemical fertiliser use
Economic benefitCost-effective, sustainableCost-effective, improves soil health
NEET Key — Important Microbe Uses
(1) Penicillium notatum — Penicillin. (2) Saccharomyces cerevisiae — Bread, Beer, Wine, Ethanol. (3) Lactobacillus — Curd, Cheese, Lactic acid. (4) Aspergillus niger — Citric acid. (5) Acetobacter aceti — Vinegar. (6) Bacillus thuringiensis — Biopesticide. (7) Rhizobium — N-fixation. (8) Methanobacterium — Biogas. (9) Trichoderma polysporum — Cyclosporin A. (10) Monascus purpureus — Statins.
Example 3 — Microbes
Which microbe is used to produce citric acid?

a) Lactobacillus   b) Saccharomyces cerevisiae   c) Aspergillus niger   d) Penicillium notatum
Solution: Option (c). Aspergillus niger (a fungus) is used for the industrial production of citric acid via fermentation of molasses/sucrose.
Example 3B — Biogas
Which group of bacteria is responsible for methane production in biogas plants?

a) Cyanobacteria   b) Methanogens   c) Rhizobium   d) Nitrosomonas
Solution: Option (b). Methanogens (Methanobacterium — an archaebacterium) are responsible for methane production in biogas plants. They produce methane by anaerobic digestion of organic matter. Cyanobacteria fix nitrogen; Rhizobium is a symbiotic N-fixer; Nitrosomonas is involved in nitrification.
Example 3C — Biofertilisers
Which cyanobacterium is associated with the water fern Azolla?

a) Nostoc   b) Anabaena azollae   c) Oscillatoria   d) Spirulina
Solution: Option (b). Anabaena azollae is a cyanobacterium that lives symbiotically in the leaf cavities of the water fern Azolla. This association is used as a biofertiliser in rice paddies, contributing nitrogen through biological nitrogen fixation.
NEET Key — Biocontrol in Agriculture
Bacillus thuringiensis (Bt) produces a protein toxin (Bt toxin) that is lethal to certain insect larvae. The gene for this toxin has been incorporated into crop plants (Bt cotton, Bt corn) through genetic engineering, making them resistant to insect pests. This is a classic example of how a natural biocontrol agent led to a major biotechnological application. NPV (Nucleopolyhedrovirus) is a species-specific viral biocontrol agent that infects only insects and is safe for non-target organisms.

Microbial Fermentation — Kinetics and Bioreactors

Industrial fermentation involves the large-scale cultivation of microorganisms to produce valuable products. Understanding fermentation kinetics is crucial for optimising yield and productivity.

Fermentation kinetics: Microbial growth in a closed system (batch culture) follows distinct phases: Lag phase — microbes adapt to the new environment, synthesising enzymes needed for substrate utilisation (no net growth). Log (exponential) phase — cells divide at a constant maximum rate (μ_max, the specific growth rate). Nutrients are abundant, waste products are minimal. Stationary phase — growth rate equals death rate due to nutrient depletion and accumulation of toxic metabolites (ethanol, organic acids). This is when secondary metabolites (antibiotics, statins) are often produced — the idophase (trophophase = growth phase, idophase = production phase). Death phase — number of viable cells declines exponentially. Key parameters: Specific growth rate (μ, h⁻¹), doubling time (t_d = ln2/μ), substrate utilisation rate, product yield (Y_p/s = g product/g substrate consumed), and productivity (g product/L/h).

Batch Fermentation: All nutrients are added at the beginning in a closed vessel. Microbes grow through all phases. Simple, low risk of contamination, flexible. Disadvantages: Low productivity due to downtime between batches (cleaning, sterilisation, re-inoculation), substrate inhibition at high initial concentrations, variable product quality between batches. Used for: High-value products (antibiotics — penicillin), enzymes, speciality chemicals.

Continuous Fermentation: Fresh nutrients are continuously added and culture fluid is continuously removed at the same rate (steady-state conditions). The system maintains cells in log phase (constant growth rate) by controlling dilution rate. Advantages: Higher productivity (no downtime), consistent product quality, better control of growth conditions. Disadvantages: Higher risk of contamination (long operation), strain degeneration (mutants may take over), complex control systems required. Used for: Single-cell protein production, ethanol production (some processes), waste treatment.

Fed-batch Fermentation: Nutrients are added incrementally during the process, but culture is not removed until the end. Combines advantages of batch and continuous — avoids substrate inhibition, allows high cell density, extends production phase. Commonly used for penicillin production — glucose is fed continuously to maintain optimal concentration without causing catabolite repression (high glucose represses penicillin synthesis).

Table: Batch vs Continuous vs Fed-Batch Fermentation
FeatureBatchContinuousFed-Batch
Nutrient additionAll at startContinuousIntermittent/incremental
Product removalAt endContinuousAt end
Growth phasesAll four phasesSteady-state (log phase maintained)Extended log/stationary
ProductivityLow (downtime between batches)High (steady operation)Moderate to high
Contamination riskLow (short runs)High (prolonged operation)Moderate
Control complexitySimpleComplex (dilution rate, sensors)Moderate (feed rate control)
Best forHigh-value products, small scaleLow-value products, large scaleProducts with catabolite repression (penicillin)

Bioreactors and Immobilised Enzymes

A bioreactor (or fermenter) is a vessel designed to provide optimal conditions for microbial growth and product formation. Key features: (1) Agitation system — impellers (Rushton turbine) for mixing and mass transfer. (2) Aeration system — sparger (ring with holes) to introduce sterile air. (3) Temperature control — cooling jacket or internal coils. (4) pH control — acid/base addition via pumps. (5) Sensors — for temperature, pH, dissolved oxygen (DO), foam detection. (6) Sterile ports — for inoculation, sampling, and addition of nutrients. (7) Foam control — foam breaker or antifoam addition. (8) Computer control system (SCADA) for monitoring and automation.

Immobilised enzymes: Enzymes that are attached to an inert support material (matrix) to allow re-use and continuous operation. Advantages: Reusability (reduces cost), increased stability (heat, pH, organic solvents), easier product recovery (enzyme separated from product), continuous processing in packed-bed reactors. Methods of immobilisation: (1) Adsorption — physical binding to a solid support (activated charcoal, silica, alumina) via weak forces (van der Waals, ionic). Simple but reversible. (2) Covalent bonding — chemical bonds between enzyme and support (agarose, cellulose, polyacrylamide). Strong binding, not reversible. (3) Entrapment — enzymes are trapped in a gel matrix (alginate beads, polyacrylamide gel, silica sol-gel). Substrate and product diffuse in/out. (4) Encapsulation — enzymes are enclosed in semi-permeable membranes (microcapsules, liposomes). (5) Cross-linking — enzymes are cross-linked to each other (CLEAs — Cross-Linked Enzyme Aggregates) using glutaraldehyde. Applications: Immobilised glucose isomerase (production of high-fructose corn syrup — the largest industrial use of immobilised enzymes), immobilised penicillin acylase (production of semi-synthetic penicillins), immobilised lipases (biodiesel production), immobilised lactase (lactose-free milk), immobilised aminoacylase (production of L-amino acids), biosensors (glucose sensor using immobilised glucose oxidase).

Industrial Production of Penicillin

Penicillin, the first antibiotic discovered (Fleming, 1928), is produced industrially by large-scale fermentation using Penicillium chrysogenum (a higher-yielding strain than P. notatum). The production process involves the following steps:

Step 1 — Strain improvement: Wild-type P. chrysogenum produces very low levels of penicillin. Strain improvement is done by mutation (UV radiation, chemical mutagens like NTG) and selection — modern strains produce >50,000 times more penicillin than Fleming's original isolate. Genetic engineering has also been used to introduce additional copies of biosynthetic gene clusters.

Step 2 — Inoculum preparation: A pure culture of the selected strain is grown in shake flasks to produce a seed culture. The seed culture is then transferred to larger seed fermenters to build up sufficient biomass for inoculation of the production fermenter (typically 5-10% v/v inoculum).

Step 3 — Production fermentation: The production fermenter (100,000-200,000 L capacity) contains a complex medium with: Carbon source (lactose or glucose — glucose is fed slowly to avoid catabolite repression), Nitrogen source (corn steep liquor — a byproduct of corn processing, rich in amino acids and nitrogen), Precursor (phenylacetic acid or phenoxyacetic acid — incorporated into the penicillin side chain), and minerals (phosphate, magnesium, sulfate). Fermentation conditions: Temperature 25-27°C, pH 6.5-6.8, dissolved oxygen maintained at >30% saturation by aeration (0.5-1 vvm) and agitation. Fermentation lasts 5-7 days in fed-batch mode.

Step 4 — Penicillin is a secondary metabolite: It is produced during the stationary (idophase) phase, not during active growth (trophophase). As glucose is depleted and growth slows, the fungus enters the production phase where penicillin biosynthetic enzymes are activated. Continuous feeding of glucose (fed-batch) maintains the culture in a prolonged production phase.

Step 5 — Recovery and purification: After fermentation, the broth is filtered to remove mycelial biomass (fungal cells). The filtrate (containing penicillin) is cooled to 0-5°C and acidified (pH 2.0-2.5) with phosphoric acid. Penicillin (an organic acid) is extracted into an organic solvent (amyl acetate or butyl acetate) by liquid-liquid extraction at low pH. The organic phase is separated and penicillin is back-extracted into a neutral aqueous buffer at pH 7.0-7.5. The buffer solution is treated with activated charcoal to remove impurities. Penicillin is crystallised by adjusting pH and adding suitable solvents. Crystals are washed, dried, and packaged under sterile conditions.

Step 6 — Semi-synthetic penicillins: Natural penicillin (Penicillin G — benzylpenicillin) can be modified to produce semi-synthetic penicillins with improved properties. The enzyme penicillin acylase (or chemical hydrolysis) removes the side chain to produce 6-APA (6-aminopenicillanic acid). Different side chains are then attached chemically to produce: Amoxicillin (broader spectrum, oral), Ampicillin (broader spectrum, oral/injectable), Methicillin (penicillinase-resistant — but now MRSA has evolved), Piperacillin (anti-pseudomonal). Semi-synthetic penicillins overcome limitations of natural penicillin: narrow spectrum, acid lability (destroyed by stomach acid — penicillin V is acid-stable), and susceptibility to β-lactamases.

NEET Key — Fermentation Conditions for Penicillin
Penicillium chrysogenum (not P. notatum — P. notatum was Fleming's original low-yielding isolate). Temperature: 25-27°C. pH: 6.5-6.8. Carbon source: Lactose or controlled glucose feed (to avoid catabolite repression — high glucose suppresses penicillin biosynthesis). Precursor: Phenylacetic acid. Penicillin is a secondary metabolite (idophase). Fed-batch fermentation is used for high yields.
NEET Key — Trophophase vs Idophase
Trophophase (growth phase) — primary metabolites produced (biomass, ethanol, organic acids). Idophase (production phase) — secondary metabolites produced (antibiotics, statins, alkaloids). Growth-associated products (e.g., ethanol from yeast): produced during log phase. Non-growth-associated products (e.g., penicillin): produced during stationary/idophase. Mixed-growth-associated products: produced during late log/early stationary phase.
Example 3I — Penicillin Production
Penicillin is classified as which type of metabolite?

a) Primary metabolite   b) Secondary metabolite   c) Growth-associated product   d) Essential metabolite
Solution: Option (b). Penicillin is a secondary metabolite produced during the idophase (stationary phase) of fungal growth, not during active growth (trophophase). Antibiotics, alkaloids, and statins are all secondary metabolites. Primary metabolites (ethanol, lactic acid, amino acids) are produced during active growth.
Example 3J — Immobilised Enzymes
Which of the following is the largest industrial application of immobilised enzymes?

a) Penicillin production   b) High-fructose corn syrup production   c) Biodiesel production   d) Lactose-free milk production
Solution: Option (b). The largest industrial use of immobilised enzymes is the production of high-fructose corn syrup (HFCS) using immobilised glucose isomerase. This enzyme converts glucose to the sweeter fructose. The process allows continuous operation with high productivity and enzyme reuse.
Example 3K — Bioreactor Types
In which type of fermentation is the culture maintained in a steady state with continuous nutrient addition and product removal?

a) Batch fermentation   b) Fed-batch fermentation   c) Continuous fermentation   d) Solid-state fermentation
Solution: Option (c). In continuous fermentation, fresh nutrients are added continuously and culture fluid is removed at the same rate, maintaining a steady state with constant cell density and growth rate (dilution rate = growth rate). This gives the highest productivity but has higher contamination risk.

Adolescence & Reproductive Health

Adolescence (10-19 years) is a critical period of physical, mental, and social development. Reproductive health education during this period is essential for: (1) Awareness about physical changes during puberty (secondary sexual characteristics, menarche, spermarche). (2) Knowledge about reproductive system and process. (3) Information about contraception, STDs, and safe sex practices. (4) Prevention of unwanted pregnancies and unsafe abortions. (5) Building healthy relationships and respect for the opposite sex. (6) Avoiding drug and alcohol abuse. The Government of India's RCH (Reproductive and Child Health Care) programme, launched in 1997, aims to provide comprehensive reproductive health services including family planning, maternal and child health, adolescent health, and STD/HIV prevention. WHO defines reproductive health as a state of complete physical, mental, and social well-being in all matters relating to the reproductive system.

Example 3G — Adolescent Health
The RCH programme in India focuses on all EXCEPT:

a) Family planning   b) Maternal and child health   c) Treatment of genetic disorders   d) Adolescent health
Solution: Option (c). The RCH (Reproductive and Child Health Care) programme focuses on family planning, maternal and child health, adolescent health, and STD/HIV prevention. Genetic disorder treatment is not a primary focus of RCH — it falls under general healthcare services.

Population Control & Family Planning

India was the first country in the world to launch a national family planning programme (1952). The goal is to stabilise the population at a level consistent with sustainable economic development. India's population has grown from 361 million (1951) to over 1.4 billion (2023) — a fourfold increase. Family planning methods include natural methods (rhythm method, withdrawal, lactational amenorrhea), barrier methods (condoms, diaphragms), IUDs, oral contraceptives, injectables, implants, and sterilisation (vasectomy, tubectomy). The total fertility rate (TFR) in India has declined from 6.0 (1951) to about 2.0 (2023) — approaching replacement level (2.1). States like Kerala and Tamil Nadu have achieved replacement level fertility. The government promotes the "small family norm" through incentives, awareness campaigns, and free contraceptive distribution. Family planning not only controls population but also improves maternal and child health by preventing high-risk pregnancies and reducing infant mortality.

NEET Key — Indian Population Milestones
(1) First family planning programme: 1952 — India. (2) National Population Policy: 2000 — aims to achieve population stabilisation by 2045. (3) TFR (Total Fertility Rate): currently ~2.0 (down from 6.0 in 1951). (4) Replacement level fertility: TFR = 2.1. (5) Most populous states: Uttar Pradesh, Maharashtra, Bihar, West Bengal. (6) Contraceptive prevalence rate in India: ~67% (NFHS-5). (7) Female literacy is the single most important factor in reducing fertility rates. (8) Age at marriage: raising the legal minimum age of marriage for women from 18 to 21 (2021 amendment) aims to improve maternal and child health.
Example 3H — Population Control
The contraceptive prevalence in India according to NFHS-5 is approximately:

a) 40%   b) 50%   c) 67%   d) 80%
Solution: Option (c). According to the National Family Health Survey-5 (NFHS-5, 2019-2021), the contraceptive prevalence rate in India is about 67%. Female sterilisation (tubectomy) is the most commonly used method (~37%), followed by condoms (~10%), and oral pills (~6%). Male sterilisation (vasectomy) usage is very low (<1%).

Life Cycle of Malarial Parasite (Plasmodium)

Malaria is caused by four species of Plasmodium: P. vivax (benign tertian malaria — fever every 48 hours), P. falciparum (malignant tertian — most severe, fever irregular, cerebral malaria), P. malariae (quartan malaria — fever every 72 hours), P. ovale (rare). Life cycle involves two hosts:

In female Anopheles mosquito (definitive host): Sexual reproduction occurs. When the mosquito bites an infected person, it ingests gametocytes (male and female) from the blood. In the mosquito's gut, gametocytes fuse to form a zygote → ookinete → oocyst → sporozoites (infective stage). Sporozoites migrate to the salivary glands.

In humans (intermediate host): (1) Sporozoites are injected when an infected mosquito bites. (2) They travel via bloodstream to the liver (hepatic stage) and invade hepatocytes. (3) In the liver, they multiply asexually (exo-erythrocytic schizogony) producing thousands of merozoites. (4) Merozoites burst out of liver cells and invade red blood cells (erythrocytic stage). (5) In RBCs, they grow and multiply (erythrocytic schizogony), rupturing RBCs and releasing more merozoites — this rupture causes the characteristic periodic fevers (chills and fever spikes). (6) Some merozoites differentiate into gametocytes (sexual stage) which can be picked up by another mosquito. Diagnosis: Blood smear examination (Gold standard) — thick and thin smears stained with Giemsa stain. Rapid diagnostic tests (RDTs) detect Plasmodium antigens. Treatment: Chloroquine (first-line for uncomplicated malaria), Artemisinin-based Combination Therapy (ACT — for drug-resistant P. falciparum), Primaquine (to prevent relapse in P. vivax by killing hypnozoites in the liver). Prevention: Mosquito control (insecticide-treated bed nets, indoor residual spraying), chemoprophylaxis for travellers, eliminating mosquito breeding sites (stagnant water).

Example 1E — Malaria
The infective stage of Plasmodium injected into humans by the mosquito is:

a) Merozoite   b) Sporozoite   c) Gametocyte   d) Oocyst
Solution: Option (b). Sporozoites are the infective stage of Plasmodium present in the salivary glands of the female Anopheles mosquito. They are injected into the human bloodstream during a mosquito bite. Merozoites cause the symptoms; gametocytes are picked up by mosquitoes.
Example 1F — Malaria Diagnosis
The most severe form of malaria with cerebral complications is caused by:

a) P. vivax   b) P. falciparum   c) P. malariae   d) P. ovale
Solution: Option (b). Plasmodium falciparum causes malignant tertian malaria, the most severe form — it can cause cerebral malaria (parasitised RBCs block brain capillaries), leading to coma and death if untreated. It is also the most drug-resistant species.

Sexually Transmitted Diseases (STDs)

STDs are infections transmitted primarily through sexual contact. Common STDs: Gonorrhoea (Neisseria gonorrhoeae — bacterium), Syphilis (Treponema pallidum — spirochaete bacterium), Chlamydiasis (Chlamydia trachomatis — intracellular bacterium), Trichomoniasis (Trichomonas vaginalis — protozoan), Genital herpes (Herpes simplex virus — HSV, viral), Genital warts (Human papillomavirus — HPV, viral), Hepatitis B (HBV — viral, also transmitted sexually), HIV/AIDS (retrovirus). Most STDs are curable except HIV, Hepatitis B, and genital herpes (can be managed but not cured). Prevention: Awareness, safe sex (condoms), avoiding multiple partners, prompt treatment, vaccination (HPV vaccine prevents cervical cancer and genital warts; Hepatitis B vaccine). STDs in early stages are asymptomatic in many cases — especially in women — making early detection difficult. If untreated, STDs can lead to: pelvic inflammatory disease (PID), infertility, ectopic pregnancy, cervical cancer (HPV), stillbirth, neonatal infections, and increased risk of HIV transmission. Diagnosis involves microscopic examination, serological tests (VDRL for syphilis), culture, and PCR-based molecular tests.

NEET Key — STD Facts
(1) Most common STD in India: Gonorrhoea. (2) Only STD with a vaccine: Hepatitis B and HPV (cervical cancer vaccine). (3) All STDs are reportable diseases in most countries. (4) VDRL test: screening test for syphilis. (5) HPV infection is the leading cause of cervical cancer — HPV vaccine (Gardasil, Cervarix) is recommended for girls aged 9-14 years. (6) Genital herpes (HSV-2) causes painful blisters and sores — can be managed with acyclovir but cannot be cured. (7) WHO estimates over 1 million new STIs (curable) occur daily worldwide.
Example 2C — STDs
Which of the following STDs is caused by a protozoan?

a) Gonorrhoea   b) Syphilis   c) Trichomoniasis   d) Genital herpes
Solution: Option (c). Trichomoniasis is caused by the protozoan Trichomonas vaginalis. Gonorrhoea (Neisseria gonorrhoeae) and Syphilis (Treponema pallidum) are bacterial. Genital herpes (HSV-2) is viral.

Antimicrobial Resistance (AMR)

Antimicrobial resistance occurs when microorganisms (bacteria, fungi, viruses, parasites) develop the ability to survive exposure to drugs that previously killed them or inhibited their growth. This is a natural evolutionary process, but it is accelerated by the misuse and overuse of antimicrobial drugs in humans, animals, and agriculture. AMR is one of the top global public health threats — it is estimated that by 2050, 10 million deaths per year could be attributable to AMR (more than cancer). Mechanisms of resistance: (1) Enzymatic inactivation — bacteria produce enzymes that destroy the drug (e.g., β-lactamases destroy penicillin — ESBL-producing bacteria are resistant to most β-lactam antibiotics). (2) Target modification — bacteria alter the drug's target site (e.g., MRSA — methicillin-resistant Staphylococcus aureus has altered PBP protein). (3) Efflux pumps — bacteria pump the drug out of the cell before it can act. (4) Reduced permeability — bacteria reduce drug entry through porins (e.g., carbapenem resistance in Pseudomonas aeruginosa). (5) Biofilm formation — bacteria form a protective matrix that prevents drug penetration. Contributing factors: Over-prescription of antibiotics, incomplete courses of treatment (bacteria survive and develop resistance), use of antibiotics in animal feed (growth promotion), lack of new drug development, poor infection control in hospitals (HAI — hospital-acquired infections). Solutions: Antibiotic stewardship (rational prescribing), completing full courses, developing new antibiotics, vaccination (prevents infections and reduces antibiotic use), improved hygiene and sanitation, infection prevention and control, limiting antibiotic use in agriculture. The WHO Global Action Plan on AMR (2015) calls for coordinated action across all sectors. India launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) in 2017.

NEET Key — AMR Mechanisms
(1) MRSA (Methicillin-resistant Staphylococcus aureus) — altered penicillin-binding protein (PBP2a) — resistant to β-lactams. (2) VRE (Vancomycin-resistant Enterococcus) — altered cell wall precursor. (3) ESBL (Extended-spectrum β-lactamase) — enzymes that hydrolyse cephalosporins. (4) Carbapenem-resistant Enterobacteriaceae (CRE) — "nightmare bacteria" — produce carbapenemases (NDM-1 — New Delhi metallo-β-lactamase) that inactivate carbapenems (last-resort antibiotics). (5) MDR-TB (Multidrug-resistant TB) — resistant to isoniazid and rifampicin. XDR-TB (Extensively drug-resistant TB) — also resistant to fluoroquinolones and aminoglycosides.
Example 2D — AMR
MRSA is resistant to which class of antibiotics?

a) Tetracyclines   b) β-lactams   c) Aminoglycosides   d) Macrolides
Solution: Option (b). MRSA (Methicillin-resistant Staphylococcus aureus) is resistant to β-lactam antibiotics (penicillins, cephalosporins, carbapenems) due to an altered penicillin-binding protein (PBP2a) encoded by the mecA gene. Vancomycin is the drug of choice for MRSA infections.

Quick Revision Tables

Table 1: Common Diseases & Their Pathogens
DiseasePathogenTypeTransmission
MalariaPlasmodium vivax/falciparumProtozoanFemale Anopheles mosquito
TuberculosisMycobacterium tuberculosisBacterialAirborne droplets
AIDSHIV (Human Immunodeficiency Virus)Viral (Retrovirus)Sexual, blood, needles, mother-to-child
TyphoidSalmonella typhiBacterialContaminated food/water (Widal test)
PneumoniaStreptococcus pneumoniaeBacterialAirborne droplets (alveoli fill with fluid)
Common coldRhinovirusViralAirborne droplets
DengueDengue virus (Flavivirus)ViralAedes aegypti mosquito
ChikungunyaCHIKV (Togavirus)ViralAedes aegypti mosquito
RingwormTrichophyton, MicrosporumFungalDirect contact with infected surfaces
FilariasisWuchereria bancroftiHelminthMosquito (Culex)
AscariasisAscaris lumbricoidesHelminthContaminated food/water (roundworm)
AmoebiasisEntamoeba histolyticaProtozoanContaminated food/water (bloody diarrhoea)
Kala-azarLeishmania donovaniProtozoanSandfly
GonorrhoeaNeisseria gonorrhoeaeBacterial (STD)Sexual contact
SyphilisTreponema pallidumBacterial (STD)Sexual contact
Table 2A: Immune Cells & Their Functions
Cell TypeLineageFunction
NeutrophilGranulocyte (myeloid)Phagocytosis — most abundant WBC, first responder, kills bacteria via NETs and ROS
MacrophageMonocyte (myeloid)Phagocytosis, antigen presentation, cytokine secretion, tissue repair
Dendritic cellMyeloidMost potent antigen-presenting cell (APC) — links innate and adaptive immunity
Natural Killer (NK) cellLymphocyte (innate)Kills virus-infected cells and tumour cells without prior sensitisation
B-lymphocyteLymphocyte (adaptive)Produces antibodies (humoral immunity), differentiates into plasma cells and memory B cells
T-helper cell (CD4+)Lymphocyte (adaptive)Activates B cells, T cells, and macrophages — "master regulators" of immune response
T-cytotoxic cell (CD8+)Lymphocyte (adaptive)Kills infected cells (cell-mediated immunity) — recognises MHC Class I + antigen
Regulatory T cell (Treg)Lymphocyte (adaptive)Suppresses immune response — prevents autoimmunity and excessive inflammation
Mast cellGranulocyte (myeloid)Releases histamine in allergic reactions — has IgE receptors, involved in inflammation
EosinophilGranulocyte (myeloid)Fights parasitic infections (helminths), involved in allergic inflammation
BasophilGranulocyte (myeloid)Releases histamine and heparin in allergic reactions — least abundant WBC
Table 2B: Industrial Microbes & Products
ProductMicrobeUse
PenicillinPenicillium notatumAntibiotic
StreptomycinStreptomyces griseusAntibiotic (TB)
Cyclosporin ATrichoderma polysporumImmunosuppressant
StatinsMonascus purpureusCholesterol-lowering
Citric acidAspergillus nigerFood acidulant
EthanolSaccharomyces cerevisiaeFuel, beverages
StreptokinaseStreptococcusClot buster
LipaseCandida rugosaDetergent additive

Practice Questions

← Reproduction Biotechnology →